Mushrooms as COVID-19 Vaccine Adjuvant

A randomized, double-blinded, placebo-controlled clinical trial to evaluate the safety of FoTv (a combination of two polypore mushrooms, Fomitopsis officinalis, and Trametes versicolor) in an adult population at the time of COVID-19 vaccination. Researchers examined the effect of FoTv vs. placebo for use as an adjunct to vaccination for COVID-19. Vaccine-related side effects following COVID-19 vaccination were examined in both study groups.

Principal Investigator(s)
Email
krupp-wellness@health.ucsd.edu

RCT of Immune Supporting Mushrooms for COVID-19

A multi-centered, randomized, double-blinded, placebo-controlled clinical trial to evaluate the safety of FoTv (a combination of two polypore mushrooms, Fomitopsis officinalis and Trametes versicolor) for COVID-positive outpatients with mild-to-moderate symptoms. Researchers used changes in COVID-19 viral load, blood markers, and a 14-day symptom diary to examine the safety, feasibility, and preliminary effects of the study product versus placebo. 


 

Principal Investigator(s)
Email
krupp-wellness@health.ucsd.edu

RCT of Chinese Herbs for COVID-19 Treatment

A multi-centered, randomized, double-blinded, placebo-controlled clinical trial to evaluate the safety of mQFPD as a modified form of Qing Fei Pai Du Tang (a Chinese herbal formula that has widely been used in Asia for COVID-positive outpatients with mild-to-moderate symptoms). Researchers used COVID-19 viral load, blood markers, and a 14-day symptom diary to examine the safety, feasibility, and preliminary effects of the study product versus placebo.

Principal Investigator(s)

Andrew Shubov, MD

Gordon Saxe, MD, PhD
Lan Kao, DACM, LAc

Email
krupp-wellness@health.ucsd.edu